120 related articles for article (PubMed ID: 27308626)
1. Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma.
Nault JC; Datta S; Imbeaud S; Franconi A; Zucman-Rossi J
Mol Cell Oncol; 2016 Mar; 3(2):e1095271. PubMed ID: 27308626
[TBL] [Abstract][Full Text] [Related]
2. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Nault JC; Datta S; Imbeaud S; Franconi A; Mallet M; Couchy G; Letouzé E; Pilati C; Verret B; Blanc JF; Balabaud C; Calderaro J; Laurent A; Letexier M; Bioulac-Sage P; Calvo F; Zucman-Rossi J
Nat Genet; 2015 Oct; 47(10):1187-93. PubMed ID: 26301494
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus in the liver: natural history and consequences in tumour development.
La Bella T; Imbeaud S; Peneau C; Mami I; Datta S; Bayard Q; Caruso S; Hirsch TZ; Calderaro J; Morcrette G; Guettier C; Paradis V; Amaddeo G; Laurent A; Possenti L; Chiche L; Bioulac-Sage P; Blanc JF; Letouze E; Nault JC; Zucman-Rossi J
Gut; 2020 Apr; 69(4):737-747. PubMed ID: 31375600
[TBL] [Abstract][Full Text] [Related]
4. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
[TBL] [Abstract][Full Text] [Related]
5. HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site.
Zhang D; Zhang K; Protzer U; Zeng C
J Clin Transl Hepatol; 2021 Jun; 9(3):399-408. PubMed ID: 34221926
[TBL] [Abstract][Full Text] [Related]
6. Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress.
Bayard Q; Meunier L; Peneau C; Renault V; Shinde J; Nault JC; Mami I; Couchy G; Amaddeo G; Tubacher E; Bacq D; Meyer V; La Bella T; Debaillon-Vesque A; Bioulac-Sage P; Seror O; Blanc JF; Calderaro J; Deleuze JF; Imbeaud S; Zucman-Rossi J; Letouzé E
Nat Commun; 2018 Dec; 9(1):5235. PubMed ID: 30531861
[TBL] [Abstract][Full Text] [Related]
7. Genomics of Viral Hepatitis-Associated Liver Tumors.
Péneau C; Zucman-Rossi J; Nault JC
J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33922394
[TBL] [Abstract][Full Text] [Related]
8. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D
Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
10. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.
Li CL; Li CY; Lin YY; Ho MC; Chen DS; Chen PJ; Yeh SH
Hepatology; 2019 Feb; 69(2):498-512. PubMed ID: 30070724
[TBL] [Abstract][Full Text] [Related]
11. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
Cevik D; Yildiz G; Ozturk M
World J Gastroenterol; 2015 Jan; 21(1):311-7. PubMed ID: 25574106
[TBL] [Abstract][Full Text] [Related]
12. AAV Infection: Protection from Cancer.
Srivastava A; Carter BJ
Hum Gene Ther; 2017 Apr; 28(4):323-327. PubMed ID: 27832705
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
[TBL] [Abstract][Full Text] [Related]
14. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
15. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
Pezzuto F; Izzo F; Buonaguro L; Annunziata C; Tatangelo F; Botti G; Buonaguro FM; Tornesello ML
Oncotarget; 2016 Aug; 7(34):54253-54262. PubMed ID: 27276713
[TBL] [Abstract][Full Text] [Related]
16. HCV core inhibits hepatocellular carcinoma cell replicative senescence through downregulating microRNA-138 expression.
Shiu TY; Shih YL; Feng AC; Lin HH; Huang SM; Huang TY; Hsieh CB; Chang WK; Hsieh TY
J Mol Med (Berl); 2017 Jun; 95(6):629-639. PubMed ID: 28258280
[TBL] [Abstract][Full Text] [Related]
17. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
[TBL] [Abstract][Full Text] [Related]
18. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
[TBL] [Abstract][Full Text] [Related]
19. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
[TBL] [Abstract][Full Text] [Related]
20. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
Ko E; Seo HW; Jung ES; Kim BH; Jung G
Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
